financetom
CISS
financetom
/
Industrials
/
CISS
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
C3is Inc.CISS
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

C3is Inc. provides international seaborne transportation services.

It provides its services to dry bulk charterers, including national and private industrial users, commodity producers and traders, oil producers, refineries, and commodities traders and producers.

The company owns and operates a fleet of two drybulk carriers, which transport major bulks, such as iron ore, coal and grains, as well as minor bulks comprising bauxite, phosphate, and fertilizers, and one Aframax crude oil tanker that transports crude oil.

C3is Inc. was founded in 2021 and is based in Athens, Greece.

Latest News >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Figma, Inc IPOs Tomorrow, Here's What You Need To Know
Figma, Inc IPOs Tomorrow, Here's What You Need To Know
Jul 30, 2025
Figma, Inc ( FIG ) IPO will take place July, 31 on the NASDAQ exchange under the ticker FIG. The company is offering shares at an expected price between $30.00 and $32.00 per share with an insider lock-up period of 180 days ending on January 27, 2026. See also: Benzinga IPO Calendar About Figma, Inc Figma ( FIG ) is...
Biogen, Eisai Alzheimer's Drug Slows Cognitive Decline in Four-Year Study
Biogen, Eisai Alzheimer's Drug Slows Cognitive Decline in Four-Year Study
Jul 30, 2025
11:00 AM EDT, 07/30/2025 (MT Newswires) -- Biogen (BIIB) and Eisai said Wednesday that four-year data from a phase 3 trial of Leqembi to treat Alzheimer's disease revealed slow progression of the disease compared to its natural course. Over the study period, the clinical dementia rating score declined by 1.75 points, implying a reduction in cognitive decline. Around 69% of...
Research Alert: CFRA Keeps Hold Opinion On Shares Of The Kraft Heinz Company
Research Alert: CFRA Keeps Hold Opinion On Shares Of The Kraft Heinz Company
Jul 30, 2025
11:05 AM EDT, 07/30/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target by $1 to $31, about 11x our 2026 EPS estimate of $2.78 (up from $2.75; 2025 raised to $2.65 from $2.59) vs. the 16x long-term...
Copyright 2023-2026 - www.financetom.com All Rights Reserved